Eupraxia Pharmaceuticals

EPRXNasdaq Canada Health Care Pharmaceuticals and Biotechnology

Market cap

$442.263 M

$6.77 +1.65%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$38.6M

Loss-making

Shares outstanding

51,939,206

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Where these numbers come from

Share counts and financials for Eupraxia Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.